In "A and Others v National Blood Authority", Mr Justice Burton highlighted Dr Gunson's evidence, where he said in concluding part of his decision: "I have already referred to Dr Gunson's evidence, subject to the question of a confirmatory assay as to 'certainly early in 1990', in retrospect. Later in cross-examination, he said...I have now said three times - I think I did say to His Lordship yesterday - that in retrospect we should have done it a different way.'" Read more about In "A and Others v National Blood Authority", Mr Justice Burton highlighted Dr Gunson's evidence, where he said in concluding part of his decision: "I have already referred to Dr Gunson's evidence, subject to the question of a confirmatory assay as to 'certainly early in 1990', in retrospect. Later in cross-examination, he said...I have now said three times - I think I did say to His Lordship yesterday - that in retrospect we should have done it a different way.'"
During the hearing of "A and Others v National Blood Authority", leading counsel for the National Blood Authority expressly accepted in relation to surrogate screening that cost should not be a determining factor and did not suggest that it should be a factor in considering routine screening. Read more about During the hearing of "A and Others v National Blood Authority", leading counsel for the National Blood Authority expressly accepted in relation to surrogate screening that cost should not be a determining factor and did not suggest that it should be a factor in considering routine screening.
Dr Barbara returned from a symposium in Paris, organised by Ortho, with a positive reaction reporting that the test seemed "reproducible, robust and meaningful". Read more about Dr Barbara returned from a symposium in Paris, organised by Ortho, with a positive reaction reporting that the test seemed "reproducible, robust and meaningful".
Dr Alter concluded that "the discovery of [Hepatitis C] is a fundamental breakthrough in virology" and went on to urge that the Ortho assay should immediately be implemented for donor screening once licensed. Read more about Dr Alter concluded that "the discovery of [Hepatitis C] is a fundamental breakthrough in virology" and went on to urge that the Ortho assay should immediately be implemented for donor screening once licensed.
By 1985, Professor Zuckerman spoke of a specific test for non-A non-B Hepatitis being "awaited with breathless anticipation", thereby conveying both the importance of developing such a test and the urgency of doing so. Read more about By 1985, Professor Zuckerman spoke of a specific test for non-A non-B Hepatitis being "awaited with breathless anticipation", thereby conveying both the importance of developing such a test and the urgency of doing so.
Professor Zuckerman explained in the "A and Others v National Blood Authority" litigation that he meant that the RIBA test was not genuinely a confirmatory test because it also tested for the antibody, rather than a comment on its unreliability as such. Read more about Professor Zuckerman explained in the "A and Others v National Blood Authority" litigation that he meant that the RIBA test was not genuinely a confirmatory test because it also tested for the antibody, rather than a comment on its unreliability as such.
At the time that the responsible minister was being informed that there was insufficient information to enable a decision to be taken, Australia was introducing routine screening, France was about to introduce it, and it had been in place in Japan since November. Read more about At the time that the responsible minister was being informed that there was insufficient information to enable a decision to be taken, Australia was introducing routine screening, France was about to introduce it, and it had been in place in Japan since November.
The incidence of non-A non-B Hepatitis in the US was 7-12%. Read more about The incidence of non-A non-B Hepatitis in the US was 7-12%.
It was generally accepted - and Dr Gunson believed - that the incidence of non-A non-B Hepatitis in the UK was 3%. Read more about It was generally accepted - and Dr Gunson believed - that the incidence of non-A non-B Hepatitis in the UK was 3%.
In "A and Others v National Blood Authority" Mr Justice Burton heard evidence from Dr Harold Gunson, who had been director of the National Blood Transfusion Service and Dr (now Professor) John Barbara, lead scientist in transfusion microbiology at the North London Blood Transfusion Centre at the relevant time, amongst other key factual and expert witnesses. Read more about In "A and Others v National Blood Authority" Mr Justice Burton heard evidence from Dr Harold Gunson, who had been director of the National Blood Transfusion Service and Dr (now Professor) John Barbara, lead scientist in transfusion microbiology at the North London Blood Transfusion Centre at the relevant time, amongst other key factual and expert witnesses.